abs91.txt	kaposi's	sarcoma-associated	herpesvirus	(kshv)	is	the	etiologic	agent	of	threehuman	malignancies		endothelial	cell	cancer	sarcoma	and	two	b	cellcancers	primary	effusion	lymphoma	multicentric	castleman's	disease	kshv	haslatent	lytic	phases	viral	life	cycle	while	both	contribute	toviral	pathogenesis	proteins	to	kshv-mediated	oncogenesis	reactivation	from	latency	driven	by	gene	transactivator	rta	transcription	controlled	epigenetic	modifications	identify	hostchromatin-modifying	that	are	involved	in	latent	transition	we	screened	a	panel	inhibitors	target	regulatory	fortheir	ability	stimulate	found	several	novel	regulatorsof	an	inhibitor	bmi1	ptc-209	additional	histonedeacetylase	romidepsin	panobinostat	bromodomaininhibitor	(+)-jq1	all	these	compounds	expression	viralgenome	replication	release	infectious	virions	treatment	with	induces	histone	at	promoter	andresults	nucleosome	depletion	this	locus	finally	silencing	induceskshv	indicating	member	polycomb	repressivecomplex	1	critical	for	maintaining
